Maya S. B.
- Country
- Spain
- Department
- Nephrology
Research Overview
- Effect of Survodutide on Albuminuria in Patients with Chronic Kidney Disease
- FINE-START; A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in participants with chronic kidney disease not using renin-angiotensin-system inhibitors
Data & Insights
Has run more than one trial at 6 of 19 partner sites.
Specializations
Nephrology and kidney disease
Clinical research interest in chronic kidney disease, end-stage renal disease, acute kidney injury, and kidney transplantation, with attention to renal protection and post-transplant outcomes.
- IgA nephropathy
- Focal segmental glomerulosclerosis
- Renal allograft rejection
- Delayed graft function
- Prophylaxis of renal allograft rejection
Therapeutic activity also includes renal complications linked to hypertension, diabetes mellitus type 2, and systemic inflammatory disease.
Autoimmune and inflammatory disease
Active involvement in immune-mediated disorders affecting the skin, joints, and connective tissue, including lupus erythematosus, psoriasis, atopic dermatitis, and hidradenitis suppurativa.
- Systemic lupus erythematosus
- Cutaneous lupus erythematosus
- Psoriatic arthritis
- Bullous pemphigoid
- Sjögren’s syndrome
Therapeutic interests extend to prurigo nodularis, vitiligo, and alopecia areata, reflecting a broad focus on chronic immune dysregulation.
Cardiovascular and metabolic disease
Research activity includes prevention and treatment of atherosclerotic cardiovascular disease, myocardial infarction, heart failure, and atrial fibrillation, alongside risk reduction in patients with metabolic comorbidity.
- Heart failure with preserved ejection fraction
- Acute ischemic stroke
- Hypertriglyceridemia
- Obesity
- Type 2 diabetes
Additional interest is seen in familial hypercholesterolemia, lipoprotein disorder, and severe symptomatic aortic stenosis.
Oncology and hematologic malignancies
Clinical trial involvement spans solid tumors and blood cancers, with emphasis on breast cancer, lung cancer, colorectal cancer, and urothelial carcinoma.
- Multiple myeloma
- Non-small cell lung cancer
- Diffuse large B-cell lymphoma
- Myelodysplastic syndrome
- Melanoma
Therapeutic focus also covers acute myeloid leukemia, lymphoma, pancreatic cancer, and prostate cancer, supporting innovation across advanced malignancies.
Respiratory, infectious, and gastrointestinal disorders
Research interests include asthma, chronic obstructive pulmonary disease, bronchiectasis, and pneumonia, with parallel work in infectious and digestive disease.
- COVID-19
- HIV infection
- Crohn’s disease
- Ulcerative colitis
- Clostridioides difficile infection
Additional therapeutic areas include allergic rhinitis, eosinophilic asthma, and metabolic dysfunction-associated steatotic liver disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.